Cardiovascular disease remains a leading cause of death,
|
|
- Grace Jacobs
- 5 years ago
- Views:
Transcription
1 Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines, Regulates NO, and Controls Blood Pressure Ben Caplin, Zhen Wang, Anna Slaviero, James Tomlinson, Laura Dowsett, Mathew Delahaye, Alan Salama, The International Consortium for Blood Pressure Genome-Wide Association Studies, David C. Wheeler, James Leiper Objective Asymmetric dimethylarginine is an endogenous inhibitor of NO synthesis that may mediate cardiovascular disease. Alanine-glyoxylate aminotransferase-2 (AGXT2) has been proposed to degrade asymmetric dimethylarginine. We investigated the significance of AGXT2 in methylarginine metabolism in vivo and examined the effect of this enzyme on blood pressure. Methods and Results In isolated mouse kidney mitochondria, we show asymmetric dimethylarginine deamination under physiological conditions. We demonstrate increased asymmetric dimethylarginine, reduced NO, and hypertension in an AGXT2 knockout mouse. We provide evidence for a role of AGXT2 in methylarginine metabolism in humans by demonstrating an inverse relationship between renal (allograft) gene expression and circulating substrate levels and an association between expression and urinary concentrations of the product. Finally, we examined data from a meta-analysis of blood pressure genome-wide association studies. No genome-wide significance was observed, but taking a hypothesisdriven approach, there was a suggestive association between the T allele at rs37369 (which causes a valine-isoleucine substitution and altered levels of AGXT2 substrate) and a modest increase in diastolic blood pressure (P=0.0052). Conclusion Although the effect of variation at rs37369 needs further study, these findings suggest that AGXT2 is an important regulator of methylarginines and represents a novel mechanism through which the kidney regulates blood pressure. (Arterioscler Thromb Vasc Biol. 2012;32: ) Key Words: alanine-glyoxylate aminotransferase-2 asymmetric dimethylarginine hypertension kidney NO Cardiovascular disease remains a leading cause of death, and hypertension is a major risk factor. 1 Although pharmacotherapy and lifestyle interventions for increased blood pressure (BP) have been a partial success, the mechanisms leading to hypertension are still incompletely understood. 2 Asymmetric methylarginines, asymmetric dimethylarginine (ADMA), and monomethylarginine are endogenous amino acids found in human plasma that inhibit NO synthesis by competing with arginine at the active site of all 3 isoforms of NO synthase (NOS). 3 High circulating levels of ADMA are a feature of renal failure, 4 cardiovascular diseases, 5 and inflammatory disorders, 6 and levels of this methylarginine predict future adverse events in population cohorts. 7,8 Regulation of asymmetric methylarginine levels is mainly through enzymatic breakdown, a reaction catalyzed by the dimethylarginine dimethylaminohydrolase enzymes (DDAHs) that degrade both ADMA and monomethylarginine. 9 Furthermore, evidence from human studies suggests that dysfunction of this methylarginine metabolizing pathway has a role in disease. 10,11 Although the DDAHs are thought to represent the main metabolic route for the removal of asymmetric methylarginines, the enzyme alanine-glyoxylate aminotransferase-2 (AGXT2) has also been suggested to have a role. AGXT2 is a nuclearencoded pyridoxal phosphate-dependent aminotransferase, which is localized to the mitochondria in rats and mice. 12,13 RNA expression 14 and proteomic 13 studies in rodents report that the enzyme is predominantly restricted to the kidney where in situ hybridization suggests that AGXT2 is expressed in tubular epithelial cells confined to the outer medulla, a site corresponding to the Loop of Henle. 14 Substrates for AGXT2 include all 3 endogenous methylarginines, that is, symmetric dimethylarginine (SDMA), ADMA, and monomethylarginine along with several other unmodified amino acids. 12 Transamination of ADMA and SDMA leads to the formation of α-keto-δ asymmetric dimethyl guanidino valeric acid Received on May 29, 2012; final version accepted on: September 10, From the Nitric Oxide Signalling Group (B.C., Z.W., A.S., J.T., L.D., M.D., J.L.), Medical Research Council Clinical Sciences Center, Imperial College London, London, United Kingdom; Center for Nephrology (B.C., A.S., D.C.W.), UCL Medical School Royal Free, University College London, London, United Kingdom. The online-only Data Supplement is available with this article at Correspondence to Ben Caplin, Center for Nephrology, UCL Medical School Royal Free, London NW3 2PF, United Kingdom. b.caplin@ucl.ac.uks 2012 American Heart Association, Inc. Arterioscler Thromb Vasc Biol is available at DOI: /ATVBAHA
2 Caplin et al AGXT2 Regulates Blood Pressure 2893 (ADGV) and α-keto-δ symmetric dimethyl guanidino valeric acid. ADGV is found in the plasma and urine. 15 Although AGXT2 has been reported to degrade exogenous ADMA in rats, 16 experimentally this occurs with a Michaelis constant (K m ) far higher than prevailing methylarginine concentrations. Recent evidence suggests that this enzyme will reduce endogenous circulating methylarginines after virus-mediated overexpression in mice. 17 However, given the highly restricted distribution and the reported kinetics of the enzyme, whether endogenous AGXT2 plays any physiological role in regulating ADMA levels in human health or disease has remained in doubt. We hypothesized that AGXT2 controls methylarginine levels in health and disease, and that the absence of AGXT2 would lead to altered hemodynamics via an increase in ADMA and a reduction in NO production. We provide both experimental (from mice) and observational (from humans) evidence that AGXT2 plays an important role in the regulation of circulating ADMA. Furthermore, the phenotype of the AGXT2-/- mouse and the results from a meta-analysis of human association studies examining a known functional mutation in the AGXT2 gene suggest that disruption of this enzyme leads to hypertension. Methods We set out to elucidate the role of AGXT2 in the regulation of ADMA and NO initially using genetically modified mice (AGXT2 knockout; AGXT2-/-). To establish the significance of the enzyme in human methylarginine metabolism, we used kidney tissue from renal transplants. In a cohort of patients undergoing allograft protocol biopsy, we examined the relationship between allograft AGXT2 expression, circulating levels of ADMA, and urinary ADGV. Finally, we examined the relationship between genetic variation in human AGXT2 and hypertension in a large meta-analysis of association studies. Animal Studies All animal experiments were performed under UK Home Office License after approval by the local ethics committee. AGXT2 haploinsufficient mice were obtained from Texas Institute of Genomic Medicine, TX, on a Sv129/C57 Bl6 mixed background. Animals were crossed against C57Bl6 animals. Homozygous and wild-type animals were obtained from F2 crosses of heterozygous founders. All experiments were performed with age- and sex-matched groups. Invasive terminal BP was measured under anesthetic (1% isoflurane). The carotid artery was cannulated with a Mikro-Tip Catheter (Millar Instruments, Austin, TX). After catheterization, hemodynamics were allowed to stabilize for 3 minutes before a measurement period of 20 to 30 cardiac cycles. All measurements were performed blind to genotype. Ex vivo aortic tension experiments were performed in a multichamber myograph (ADInstruments, Oxford, UK). Freshly retrieved aortic rigs were mounted in the chamber and were allowed to equilibrate in physiological saline solution at 37 C in 5% CO 2. Vessels were precontracted to a tension of 10 mn and were stimulated with noradrenaline and potassium. After washing, responses to increasing concentrations (i) phenylephrine, PE; (ii) acetylcholine (ACh); following 80% maximal PE contraction; (iii) ADMA, following 20% maximal PE contraction; and (iv) sodium nitroprusside, following 80% maximal PE contraction, were quantified. Vessels were washed and tension was allowed to return to baseline between treatments. Two rings from each animal were examined and the average response was taken except where vessels failed to relax (>25%) in response to ACh, in which case, data were discarded. Organs for histology were retrieved after death and fixed overnight (4% paraformaldehyde). Sections were stained using periodic acidschiff and were examined blind to genotype. Renal Transplant Cohort Research ethics committee and National Health Service management approval were obtained for the transplant cohort study, which was conducted in accordance with Declaration of Helsinki principles. Written informed consent was obtained from all subjects. The transplant biopsy cohort consisted of patients undergoing protocol biopsy after kidney transplantation as per routine clinical care. Subjects were recruited from the Royal Free Hampstead National Health Service Trust transplant clinic. Patients who refused biopsy or had clinical contraindications to protocol biopsy were not approached. All biopsies were examined by a consultant histopathologist to confirm adequate sampling and the absence of rejection. Contemporaneous blood and urine samples were collected and frozen until further analysis. Biochemical Measurements Measurements of routine biochemical variables in patient samples were performed by National Health Service hospital laboratories. Urinary creatinine was measured by Jaffe method. Methylarginine, amino acids, and dimethyl guanidino valeric acid levels were quantified using liquid chromatography tandem mass spectrometry using a modification of methods previously described. 15,18 Briefly, an internal standard (deuterium [d7]-labeled ADMA, Cambridge Isotope Laboratories) was added to 50 or 100 µl of biological samples (plasma, urine, tissue lysate, enzyme assay) before precipitation in 5 volumes of methanol. After centrifugation ( rpm for 10 minutes at 4ºC), 100 to 200 µl of the supernatant was vacuum dried for 2 hours using a refrigerated vacuum dryer. Liquid chromatography tandem mass spectrometry was performed using an agilent triple pole liquid chromatography tandem mass spectrometry. A hypercarb (Thermo Scientific) chromatography column was used and the mobile phase consisted of 0.1% formic acid, 1% acetonitrile (increasing to 50% between 5 and 10 minutes) over a total run time of 15 minutes. The mass spectrum parameters were as follows: ADMA, mass-to-charge ratio (m/z): to 46.0, collision energy (CE): 12; SDMA, m/z: to 70.2, CE: 24; monomethylarginine, m/z: to 70.2, CE: 24; arginine, m/z: to 60.1, CE: 8; alanine, m/z: 90.1 to 44.1, CE: 4; citrulline, m/z: to 86.2, CE: 16; glutamine, m/z: to 56.3, CE: 0; dimethyl guanidino valeric acid, m/z: to 70.1, CE: 8 d7-adma, m/z: to 46.0, CE: 24. Standard curves were generated for each substance of interest. Amino acid standards were obtained as free bases (Sigma) and methylarginines as hydrochloric acid salts (Calbiochem). Dimethyl guanidino valeric acid was generated by hydrolysis of ADMA in methanol at 98 C in the presence of pyruvate with the production confirmed by mass spectra and concentration determined by the stoichiometric disappearance of ADMA. cgmp, aldosterone, and renin were quantified by enzyme-linked immunoassay according to manufacturer s instructions (Enzo Life Sicences, and R&D Systems for renin). NOx (NO2 and NO3) was measured with a Sievers Nitric Oxide Analyzer as per protocol. Protein concentrations were determined by Bradford assay. Enzyme Assays Assays were performed on mitochondrial isolates (Mitochondria Isolation Kit, Thermo Scientific, MA). Mitochondria were suspended in 25-mmol/L HEPES, 0.1-mmol/L EDTA, 12.5-mmol/L MgCl 2, 100-mmol/L KCl, 10% glycerol (v/v), 0.1% Nonidet P-40 (v/v), and 5-mmol/L dithiothreitol with protease inhibitors (Roche complete as per instructions). Reactions were performed in a 0.1-mol/L potassium phosphate reaction buffer with ADMA and an amino acceptor (pyruvate) in 4 molar excess. All reactions were performed in the presence of 20-μmol/L pyridoxal-5-phosphate, and the ph was adjusted to 7.5 before the assay. Fifty micrograms of mitochondrial protein was used in a 60-µL reaction with final ADMA concentrations of 10 6, 10 5, 10 4, and 10 3 mol/l. ADGV was quantified and enzymatic production was calculated from the total concentration minus the concentration measured in negative controls (substrate solutions at each ADMA concentration without mitochondrial protein). NOS activity was determined in whole kidney lysates by quantification of the difference in the disappearance of L-arginine with and without the addition of the NOS inhibitor, NG-nitro-L-arginine.
3 2894 Arterioscler Thromb Vasc Biol December 2012 Kidneys were homogenized in a proprietary reaction buffer (NOS activity kit, Cayman Chemical, Denver, CO) and reactions were performed at 37 C for 1 hour in the presence 1-mmol/L L-arginine. Disappearance of L-arginine was quantified by liquid chromatography tandem mass spectrometry. Molecular Biology All tissues were immediately immersed in RNAlater solution (Qiagen, Hilden, Germany) before being frozen. RNA was extracted using a column system (RNeasy plus micro, Qiagen) and resulting RNA was reverse transcribed using qscript complementary DNA Synthesis Kit (Quanta Biosciences, MD, human samples) or iscript Supermix (Biorad, Hertfordshire, UK, mouse samples). Primers were designed to amplify complementary DNA from mouse and human DDAH1 and AGXT2, and are listed in the Online Appendix (Table IV in the online-only Data Supplement). Primers for human control genes have been reported previously. 11 For human studies, absolute quantification of complementary DNA was performed on a 7900HT Real-Time PCR System (Applied Biosystems, CA). Quantitative reverse transcription polymerase chain reaction (qrt-pcr) results from the genes of interest were normalized to the 3 most stable of 6 control genes: β-actin (ACTβ), β-2 microglobulin (β2m), and TATA box binding protein (TBP). For mouse studies, genes of interest were normalized to the number of copies of DNA polymerase subunit 2 (POL2). All reactions were performed in triplicate. Tissues for protein analysis were initially snap frozen in liquid nitrogen (and stored at -80 C) before homogenization in PBS with protease inhibitors (Roche complete). Western blots were performed after gel electrophoresis using standard techniques. Goat anti-ddah1 antibodies were generated as previously described 19 and rabbit polyclonal anti-endothelial NOS (enos) and phospho-enos (Ser1177) antibodies were obtained commercially (Cell Signalling, MA). Rabbit anti-α tubulin, anti-α acetyl-coa carboxylase antibodies (Cell Signalling), and infrared secondary antibodies (Invitrogen Corporation, NY and Li-Cor, NE) were also obtained commercially. Despite attempts with numerous custom-generated antibodies, no specific detection of AGXT2 in tissue lysates could be achieved. Statistical Methods All data in text are presented as mean with 95% CIs (or median and interquartile range for non-normally distributed variables). Either Figure 1. Alanine-glyoxylate aminotransferase-2 (AGXT2)-/- mouse: Generation and methylarginine concentrations. A, Generation of the AGXT2-/- mouse. Exons 8 and 9 of the AGXT2 gene in chromosome 15 were deleted and replaced by SA-bGeo/Puro cassette; B, AGXT2 gene expression in AGXT2-/- and (wild-type) WT mice. RNA was quantified by qrt-pcr. Gene expression was normalized to polymerase II subunit 2 A. AGXT2 gene expression was absent in the aortas of both WT and AGXT2 mice. n=6 per group; C, Plasma methylarginines and asymmetric dimethyl- guanidinovaleric acid (ADGV) measured by liquid chromatography tandem mass spectrometry (LC-MS/ MS). n=11 to 12 per group; D, Plasma amino acids measured by LC-MS/MS. n=11 to 12 per group; E, Tissue concentrations of ADGV in WT and AGXT2-/- mice. n=4 5 per group. Significant amounts of ADGV could only be detected in the kidney of WT mice. 95% CI of the mean for all other tissues and AGXT2-/- kidney include 0; F, Tissue concentrations of ADMA in WT and AGXT2-/- mice. n=4 to 5 per group. PCR indicates polymerase chain reaction; ADMA, asymmetric dimethylarginine; SDMA, symmetric dimethylarginine; MMA, monomethylarginine. *P<0.05; **P<0.01; ***P<0.005 by Student t test.
4 Caplin et al AGXT2 Regulates Blood Pressure 2895 a t test, or Mann-Whitney U test for nonparametric data, was used to examine for differences in continuous variables between groups. Univariate associations between continuous variables were examined using Pearson correlation coefficient (or Spearman rank correlation for skewed data). Log transformation was used where this normalized the distribution of a variable (plasma ADMA and SDMA in human cohort). We used linear regression to adjust for the effects of prespecified potential confounders on the relationship between plasma methylarginines and AGXT2 expression, that is, age, sex, ethnicity, estimated glomerular filtration rate (egfr), and DDAH expression. egfr was calculated using the modified-diet in renal disease equation. Statistical significance was accepted as P<0.05. Data were analyzed in Stata version 11 and Prism version 5. The description of cohorts and the data analysis approach for the meta-analysis of the International Consortium for Blood Pressure Genome-Wide Studies have been reported elsewhere. 20 Results AGXT2 Knockout Mice Have Raised ADMA Originating From Reduced Transamination Disruption of the AGXT2 gene was achieved through the insertion of a SA-bGeo/Puro cassette in place of exons 8 and 9 (Figure 1A). AGXT2-/- and wild-type groups were generated from heterozygous founders and animals, produced in mendelian ratios, were of normal weight with no observed gross developmental abnormality (Table I in the online-only Data Supplement). Absence of AGXT2 gene expression and enzyme activity was confirmed in the kidney (Figures 1B and 2). Circulating levels of all 3 endogenous methylarginines were increased and plasma ADGV was substantially reduced in the circulation of AGXT2-/- mice (Figure 1C). No differences were found in the circulating levels of L-alanine, L-arginine, or L-glutamine, although a small but statistically significant increase in L-citrulline was observed (Figure 1D). Whereas significant amounts of ADGV were detected only in wild-type kidney (Figure 1E), changes in ADMA were demonstrated in other organs (Figure 1F). Next, we examined the consequences of AGXT2 deletion on DDAH1, the enzyme thought to play the major role in ADMA turnover, 21 and enos in the kidney and aorta. No compensatory increase in the gene or protein (kidney only) expression of DDAH1 could be identified (Figures 3A 3D). Similarly, we could not detect any differences in enos expression at the messenger RNA level nor any significant changes in enos protein or phosphorylation, although there was a trend toward an increase in phosphorylation in the kidney of AGXT2-/- animals (Figure 3A, 3B, and 3E 3G). Kidney Mitochondrial Isolates Demonstrate Enzymatic Transamination of Methylarginines To demonstrate enzyme activity at physiological methylarginine concentrations, we performed assays on isolated mitochondria from the kidneys of both wild-type and AGXT2-/- mice. ADGV production was demonstrated after incubation of mitochondrial fractions with ADMA at concentrations between 1 μmol/l and 1 mmol/l without evidence of enzyme saturation (Figure 2). Specific activities at 37 C, ph 7.5, were 3.3 (95% CI ), 25.7 (95% CI ), and (95% CI ) nmoles min 1 mg 1 of mitochondrial protein at substrate concentrations of 1, 10, 100 μmol/l, respectively. Enzymatic activity was supported by the reduction of activity at 4 C and absence of activity in isolates from AGXT2-/- mice. Although previous reports have suggested that the affinity of AGXT2 for ADMA is low (K m =14 mmol/l), these data suggest that the endogenous enzyme deaminates endogenous methylarginines at the prevailing intracellular ADMA concentrations observed in health and disease. AGXT2 Knockout Mice Are Hypertensive Invasive terminal BPs were measured in male animals aged 8 to 9 weeks, under terminal anesthesia. There was clear evidence of hypertension in the AGXT2-/- mice as assessed by mean BP (Figure 4A), but no differences in heart rate (Figure 4B). To investigate the mechanism underlying the hypertension in AGXT2-/- mice, we examined the NO pathway, the reninangiotensin-aldosterone system (because higher renin has been reported in enos knockout mice), 22 and renal histology. Consistent with the increase in plasma ADMA, there was a decrease in circulating NOx in AGXT2-/- mice (Figure 4C). In knockout animals, there was a suggestion that plasma renin levels were suppressed rather than increased (Figure 4D), although the differences did not reach predetermined levels of statistical significance (P=0.08), and aldosterone levels were similar (Figure 4E). Given the increases in endogenous methylarginines observed in other tissues, we also examined downstream NO-dependent signaling but could not identify significant differences in cgmp (Table I in the online-only Data Supplement). ADGV, µm per milligram mitochondrial protein per minute ADMA, µm WT 4 C WT 37 C AGXT2-/- 4 C AGXT2-/- 37 C Figure 2. Enzyme activity in isolated mitochondria. Enzyme assays for alanine-glyoxylate aminotransferase-2 (AGXT2) performed in the isolated mitochondrial fraction of kidney homogenates from WT and AGXT2-/- mice at 4 C and 37 C. Mitochondrial isolates were incubated in substrate for 1 h and showed temperature-dependent production of asymmetric dimethyl- guanidinovaleric acid (ADGV) at concentrations of asymmetric dimethylarginine (ADMA) across the physiological range. n=3 for each time point and condition. Error bars: SE of the mean. WT indicates wild-type; AGXT2-/-, AGXT2 knockout.
5 2896 Arterioscler Thromb Vasc Biol December 2012 A B C D Figure 3. Dimethylarginine dimethylaminohydrolase (DDAH1) and endothelial NO synthase (enos) in the alanine-glyoxylate aminotransferase-2 (AGXT2)-/- mouse. A, Expression of DDAH/eNOS in the kidney of AGXT2-/- and wild-type (WT) mice. RNA was quantified by qrt-pcr. Gene expression was normalized to polymerase II subunit 2 (POL2A). n=6 per group; B, Expression of DDAH/eNOS in the aorta of AGXT2-/- and WT mice. RNA was quantified by qrt-pcr. Gene expression was normalized to POL2A. n=6 per group; Densitometry (C) and representative Western blot of kidney lysates probed for DDAH1 from AGXT2-/- and WT mice (D). n=6 per group; Densitometry of Western blot of kidney lysates probed for enos (E) and phosphorylated (serine 1177) enos (p-enos) in AGXT2-/- and WT mice (F) with representative blots (G). No significant differences were seen. ACC indicates Acetyl-CoA carboxylase (P=0.09 for a difference in phosphoenos between AGXT2-/- and WT). E F G αacc enos p-enos To further characterize the changes in NO production we examined tissues from the AGXT2-/- mouse ex vivo. NOS activity in kidney homogenates was not reduced under experimental conditions where substrate was present in excess (Figure 4F). There were no differences in isolated aortic rings in responses to PE between genotypes (Figure 4G). As would be predicted, the aortas from AGXT2-/- mice (which do not express AGXT2, Fig 1B) demonstrated no reduction in endothelium-dependent relaxation when free from exposure to high ADMA in the animals circulation. Instead, we identified an increase in maximal response to acetylcholine (but no change in EC50) in knockout mice (Figure 4H). We also identified an increase in tension in the aortas from animals of both genotypes in response to ADMA at concentrations similar to the magnitude of the increase in concentration seen in the plasma of AGXT2-/- mice (Figure 4I). There was a similar relaxation in response to sodium nitroprusside in both groups (Figure 4J). Finally, histological examination of the kidneys revealed no evidence of abnormal development as a consequence of AGXT2 deletion (Figure 4K and 4L). Renal Allograft AGXT2 Expression Is Inversely and Independently Associated With Plasma ADMA To investigate if AGXT2 regulates methylarginine levels in humans, we quantified tissue AGXT2 expression and examined the associations with concentrations of substrate and product. The cohort is outlined in the Table. None of the allograft biopsies showed active rejection on histological examination. Relative allograft AGXT2 messanger RNA expression levels, determined by qrt-pcr, were strongly inversely associated with both (log) ADMA and (log) SDMA in contemporaneous blood samples (Figure 5A and 5B). AGXT2 expression was also associated with DDAH1 but not DDAH2 levels. Although there was a suggestion of an association between egfr and DDAH1 expression, there was no association between egfr and AGXT2 (Table II in the online-only Data Supplement). To test whether the association between methylarginines and AGXT2 was accounted for by potential confounders, for example, DDAH expression or kidney function, we developed multivariable regression models. After adjustment of the model for potential confounders including DDAH1
6 Caplin et al AGXT2 Regulates Blood Pressure 2897 A B G I C D E H J F K L Figure 4. Blood pressure and mechanisms of hypertension in the alanine-glyoxylate aminotransferase-2 (AGXT2)-/- mouse. A, Mean arterial pressure measured by carotid artery cannulation under anesthesia. Male mice aged 8 to 9 wks old, n=6 per group; B, Heart rate measured by carotid artery cannulation under anesthesia. Male mice aged 8 to 9 wks, n=6 per group; C, Plasma NOx in animals fed on normal chow. n=11 (wild-type [WT]) and 12 (AGXT2-/-). D, Plasma renin levels measured by ELISA. n=9 per group. P=NS (0.09) by Student t test; E, Plasma aldosterone levels measured by ELISA. n=7 per group. F, NO synthase (NOS) activity in kidney lysates from AGXT2-/- and WT mice in the presence of 1 mmol/l L-arginine. (G J) Ex vivo aortic responses to vasoactive compounds. n=6 per group. White circles: WT; Black circles: AGXT2-/-. Representative sections of cortex (K) and vascular pole (L) from the kidneys of WT (left) and AGXT2 / (right) mice. Periodic acid-schiff stain. No gross structural abnormalities in glomeruli, tubules or vessels were observed. ADMA indicates asymmetric dimethylarginine; PE, phenylephrine; ACh, acetylcholine; SNP, sodium nitroprusside. *P<0.05, **P<0.01 by Student t test. P<0.05 by Mann-Whitney U test. expression, age, sex, ethnicity, and egfr, the strong inverse association between relative gene expression and circulating methylarginines remained (partial R 2 =0.21; P=0.009 and partial R 2 =0.20; P=0.011 for ADMA and SDMA, respectively, in the models including patient factors and DDAH1 expression; see Table III in the online-only Data Supplement). Median urinary ADGV concentrations, the product of AGXT2 metabolism of ADMA, were 0.31 μmol/mmol creatinine (interquartile range ). There was a correlation between AGXT2 gene expression and urinary concentrations of the ADGV (n=38, Spearman ρ=0.37, P=0.02). However no association between BP, or BP surrogates (number of antihypertensive medications), and AGXT2 expression was observed in this cohort. Association Between Genetic Variation in the Human AGXT2 Gene and BP Using data from the International Consortium for BP Genome- Wide Studies, 20 we evaluated single-nucleotide polymorphisms spanning up to megabase on either side of AGXT2 on human chromosome 5. There were no results that support an association of this locus and BP using genome-wide thresholds for statistical significance from a meta-analysis of over subjects of European ancestry with 2.5 million directly typed or imputed single-nucleotide polymorphisms. However, taking a hypothesis-driven approach, we specifically examined the association between genotype rs37369, the V140I substitution associated with an increase in AGXT2 substrate levels, 14 and BP in the same dataset. In an additive model, each minor allele at rs37369 was associated with an increase of 0.31±0.11 mm Hg in diastolic BP and an increase of 0.31±0.18 mm Hg in systolic BP (P= and P=0.076, respectively). Discussion In this series of studies, we provide strong evidence that AGXT2 metabolizes endogenous methylarginines in vivo and disruption of this enzyme also leads to reduced NO bioavailability and hypertension. Recent reports have concluded that dysfunction of this enzyme is responsible for hyper β-aminoisobutyric aciduria in humans 14 by observing an
7 2898 Arterioscler Thromb Vasc Biol December 2012 Table. Clinical Characteristics of the Transplant Cohort (n=40) Whole Cohort (n=40) Age at transplant, years 48±13.2 Female recipient, n (%) 20(50.0) Black recipient, n (%) 14(35.0) Diabetes, n (%) 3(7.5) Donor age, years 53±13.9 Female donor, n (%) 14(35.0) Black donor, n (%) 2(5.0) Live donor, n (%) 11(27.5) Unfavourable match, n (%) 31(77.5) DGF, n (%) 21(52.5) Prior rejection episode, n (%) 2(5.0) Taking ACE or ARB, n (%) 5(12.5) Follow up, days 281±86 Tacrolimus level, ng/ml 9.2±2.8 Cold ischemic time, hours, median (range) 12(0 to 24) Tacrolimus level, ng/ml 9.2±2.8 DGF indicates delayed graft function; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; HLA, human leukocyte antigen. Unfavorable match was defined as per UK blood and transplant definitions that is as >1 mismatch at either HLA-A or HLA-B locus or any mismatch at HLA-DR. DGF was defined as either failure for the serum creatinine to fall by 30% on d 2 or dialysis dependence at 1 wk after transplant. Data are mean±sd unless otherwise stated. association between the V140I substitution and urinary levels of this non-methylarginine substrate. Hyper β-aminoisobutyric aciduria has been considered a benign syndrome of altered urinary metabolites, 23 however, to the best of our knowledge no systematic investigation of methylarginines or vascular phenotype has been performed in these patients. Other investigators have shown that this enzyme can metabolize ADMA under experimental conditions, 16,17 however, our study provides the first convincing evidence that endogenous AGXT2 contributes to the regulation of circulating methylarginines at physiological substrate concentrations. Allograft protocol biopsies are a relatively unique opportunity to examine the relationships between tissue-level enzyme expression and circulating substrates and enzyme products. The observation that tissue levels of AGXT2 messanger RNA are correlated with urinary concentrations of ADGV (a metabolic product of AGXT2) and strongly and inversely associated with levels of the substrates is consistent with a role for this enzyme in the regulation of circulating endogenous methylarginines in humans. Furthermore, the (inverse) association with SDMA (which is not a substrate for the DDAHs), and the finding that the relationship with ADMA is independent of DDAH1 and DDAH2 gene expression, suggest that AGXT2 is a source of significant methylarginine turnover in addition to these bettercharacterized enzymes. Indeed, we estimated that the variation in AGXT2 expression accounted for approximately 20% of the variation in both (log) ADMA and (log) SDMA after adjusting for other variables (including DDAH1 gene expression) in our patients, a magnitude of change in ADMA that has been associated with cardiovascular events. The lack of associations observed between human AGXT2 gene expression levels and hypertension in this cohort are unsurprising given the small numbers and multiple contributing factors to BP after transplantation. Consistent with the observational data from patients, disruption of the AGXT2 gene in mice led to an elevation in all 3 endogenous methylarginines. In vitro activity assays confirm that enzymatic degradation of ADMA by AGXT2 occurs in the mitochondrial compartment at physiological ph and substrate concentrations. These data are consistent with evidence from the DDAH1 knockout mouse, where disruption of metabolism also leads to an increase in circulating methylarginines. 24 The relative increase in ADMA is smaller with AGXT2 than with homozygous DDAH1 deletion, 21 perhaps reflecting the limited distribution of this enzyme. Because SDMA is also a substrate for AGXT2, as would be predicted, this was also elevated in the AGXT2-/- mouse. Reductions in the concentration of the product of methylarginine deamination along with absence of A log ADMA Concentration, µm B log SDMA Concentration, µm relative AGXT2 expression relative AGXT2 expression Figure 5. Association between circulating methylarginines and allograft alanine-glyoxylate aminotransferase-2 (AGXT2) expression in the renal transplant cohort. A, Asymmetric dimethylarginine (ADMA) and gene expression. Pearson R 2 =0.30; P= B, Symmetric dimethylarginine (SDMA) and gene expression. Pearson R 2 =0.27; P= Relative AGXT2 expression levels were quantified from kidney allograft protocol biopsies and methylarginines measured by liquid chromatography tandem mass spectrometry in contemporaneously obtained plasma samples. n=35 for both analyses.
8 Caplin et al AGXT2 Regulates Blood Pressure 2899 enzyme activity in vitro confirm the metabolic consequences of AGXT2 deletion. The alterations in ADMA identified at sites remote from both AGXT2 expression and dimethyl- guanidinovaleric acid detection in this study suggest that there is a significant contribution of this kidney enzyme to plasma methylarginine levels which are then reflected in other tissues. It is interesting that unlike the brain and liver, the increase in ADMA observed in the kidneys of AGXT2-/- mice was not significant. The localization of AGXT2 to the outer medulla (from which venous blood re-enters the circulation without passing through the renal cortex) means that this pathway may predominantly regulate circulating rather than renal interstitial methylarginine levels. We also performed the characterization of related pathways, and although we observed an increase in circulating citrulline in the AGXT2-/- mice, this is unlikely to reflect increased hydrolysis of ADMA because we could identify no compensatory increases in DDAH1 at protein or RNA level. However, the observed increase in aortic maximal response to acetylcholine ex vivo (along with the trend toward increased renal enos phosphorylation) strongly suggests a partial compensatory response to chronic inhibition of enos in vivo. Furthermore, we could detect no decreases in cgmp in any organ studied. Again, this may reflect compensatory differences in NOS activity, changes in substrate availability (thereby altering arginine to ADMA ratios), or a secondary adaptive response via an increase in the activity of soluble guanylate cyclase. Similar compensatory upregulation of downstream pathways has been reported in previous models of chronic NOS inhibition. 24,25 The second important finding of our studies indicates that disruption of AGXT2 leads to hypertension. Knockout of DDAH 21 and enos 26,27 also leads to an increase in BP and a reduction in NO bioavailability, 28 through an increase in ADMA in the case of the DDAH1 knockout. In AGXT2-/- mice, the increase in plasma ADMA was smaller than in DDAH1-/- mice ( 25% versus almost a doubling); however, the reduction in plasma NO species seems similar between AGXT2-/-, enos-/-, and DDAH1-/- mice (25 50%), and the increase in mean BP (10 20 mm Hg) was also comparable. We investigated the mechanisms underlying the hypertension in AGXT2-/- mice. We could find no evidence of kidney damage or for a renin-angiotensin-aldosterone systemmediated increase in BP. Nor was there the suggestion of a reduction in NOS activity ex vivo, underlined by the observation that ex vivo aortas from AGXT2-/- mice actually show evidence of enhanced endothelium-dependent responses. However, the finding that these vessels constrict in response to an increase in ADMA concentration (of similar magnitude to that observed in the plasma of these animals) is consistent with a mechanism of competitive inhibition of endotheliummediated vasodilation in vivo underlying the hypertension. The failure of the gene variation at this locus to reach statistical significance after correction for multiple comparisons in the meta-analysis of genome-wide association studies for BP suggests that polymorphisms in AGXT2 are not responsible for a significant proportion of BP heritability in the European population. The low minor allele frequency ( 8% in whites) of the functional variant in the European population means that the power to detect an association between variation at this locus and hypertension, using genome-wide thresholds for significance, is low. 29 However, taking a hypothesis-driven approach, the V140I substitution, for which there is strong evidence for a functional effect on enzyme activity, was associated with a modest but significant increase in diastolic BP. Further study of the effect of V140I substitution on methylarginine levels in different patient groups and replication of the BP findings in another cohort (of an ethnicity with a higher minor allele frequency) should be undertaken. However, alongside the hypertension demonstrated in the AGXT2-/- mouse, these observations from human association studies, provide strong evidence for a role for AGXT2 in the regulation of BP. In summary, we confirm the importance of a second route of methylarginine metabolism with functional consequences on cardiovascular homeostasis. Further investigation of this pathway is required to better understand the underlying biology, however, the restricted expression pattern of this enzyme may make it a potentially useful target in the treatment of hypertension. Acknowledgments We gratefully acknowledge the assistance of the staff of the Renal Transplant Unit at the Royal Free Hampstead National Health Service Trust in obtaining research material from protocol biopsies. Sources of Funding B.C. received support from the Academy of Medical Sciences (in collaboration with the Wellcome Trust and British Heart Foundation). J.L. received support from the Medical Research Council and British Heart Foundation. None. Disclosures References 1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360: Kotchen TA. Historical trends and milestones in hypertension research: a model of the process of translational research. Hypertension. 2011;58: Leiper J, Nandi M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat Rev Drug Discov. 2011;10: Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339: Schulze F, Lenzen H, Hanefeld C, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J. 2006;152:493.e1 493.e8. 6. Dooley A, Gao B, Bradley N, Abraham DJ, Black CM, Jacobs M, Bruckdorfer KR. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology (Oxford). 2006;45: Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation. 2009;119: Leong T, Zylberstein D, Graham I, Lissner L, Ward D, Fogarty J, Bengtsson C, Björkelund C, Thelle D; Swedish-Irish-Norwegian
9 2900 Arterioscler Thromb Vasc Biol December 2012 Collaboration. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol. 2008;28: Palm F, Onozato ML, Luo Z, Wilcox CS. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol. 2007;293:H3227 H Ding H, Wu B, Wang H, Lu Z, Yan J, Wang X, Shaffer JR, Hui R, Wang DW. A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. Circ Res. 2010;106: Caplin B, Nitsch D, Gill H, Hoefield R, Blackwell S, MacKenzie D, Cooper JA, Middleton RJ, Talmud PJ, Veitch P, Norman J, Wheeler DC, Leiper JM. Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms. Kidney Int. 2010;77: Ogawa T, Kimoto M, Sasaoka K. Dimethylarginine:pyruvate aminotransferase in rats. Purification, properties, and identity with alanine:glyoxylate aminotransferase 2. J Biol Chem. 1990;265: Pagliarini DJ, Calvo SE, Chang B, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell. 2008; 134: Suhre K, Wallaschofski H, Raffler J, et al. A genome-wide association study of metabolic traits in human urine. Nat Genet. 2011;43: Martens-Lobenhoffer J, Rodionov RN, Drust A, Bode-Böger SM. Detection and quantification of α-keto-δ-(n(g),n(g)- dimethylguanidino)valeric acid: a metabolite of asymmetric dimethylarginine. Anal Biochem. 2011;419: Ogawa T, Kimoto M, Watanabe H, Sasaoka K. Metabolism of NG,NGand NG,N G-dimethylarginine in rats. Arch Biochem Biophys. 1987;252: Rodionov RN, Murry DJ, Vaulman SF, Stevens JW, Lentz SR. Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production. J Biol Chem. 2010;285: Maas R, Tan-Andreesen J, Schwedhelm E, Schulze F, Böger RH. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;851: Arrigoni FI, Vallance P, Haworth SG, Leiper JM. Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation. 2003;107: Ehret GB, Munroe PB, Rice KM, et al; International Consortium for Blood Pressure Genome-Wide Association Studies; CARDIoGRAM consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen consortium; CHARGE-HF consortium. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478: Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, Chen Y. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arterioscler Thromb Vasc Biol. 2011;31: Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1996;93: Gartler SM. An investigation into the biochemical genetics of beta-aminoisobutyric aciduria. Am J Hum Genet. 1959;11: Leiper J, Nandi M, Torondel B, et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med. 2007;13: Brandes RP, Kim D, Schmitz-Winnenthal FH, Amidi M, Gödecke A, Mülsch A, Busse R. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension. 2000;35: Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377: Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the United States of America. 1996;93: Bryan NS, Calvert JW, Gundewar S, Lefer DJ. Dietary nitrite restores NO homeostasis and is cardioprotective in endothelial nitric oxide synthase-deficient mice. Free Radic Biol Med. 2008;45: Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet. 2008;40:
Cardiovascular disease remains a leading cause of death,
Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines, Regulates NO, and Controls Blood Pressure Ben Caplin, Zhen Wang, Anna Slaviero, James Tomlinson, Laura Dowsett, Mathew Delahaye,
More informationTargeting intracellular arginine / asymmetric dimethylarginine (ADMA).
Targeting intracellular arginine / asymmetric dimethylarginine (ADMA). From bench to practice: Novel anti-atherogenic strategies to improve endothelial function Rainer H. Böger, M.D. Institute of Clinical
More informationSupplemental Figure I
Supplemental Figure I Kl ( mmol/l)-induced Force orta M (mn) 1 (mn) 1 Supplemental Figure I. Kl-induced contractions. and, Kl ( mmol/l)-induced contractions of the aorta () and those of mesenteric arteries
More informationSUPPLEMENTAL MATERIAL. Supplementary Methods
SUPPLEMENTAL MATERIAL Supplementary Methods Culture of cardiomyocytes, fibroblasts and cardiac microvascular endothelial cells The isolation and culturing of neonatal rat ventricular cardiomyocytes was
More informationrenoprotection therapy goals 208, 209
Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationSupplementary Information Titles Journal: Nature Medicine
Supplementary Information Titles Journal: Nature Medicine Article Title: Corresponding Author: Supplementary Item & Number Supplementary Fig.1 Fig.2 Fig.3 Fig.4 Fig.5 Fig.6 Fig.7 Fig.8 Fig.9 Fig. Fig.11
More informationEvidence for Dysregulation of Dimethylarginine Dimethylaminohydrolase I in Chronic Hypoxia Induced Pulmonary Hypertension
Evidence for Dysregulation of Dimethylarginine Dimethylaminohydrolase I in Chronic Hypoxia Induced Pulmonary Hypertension Lesley J. Millatt, PhD; Guy StJ. Whitley, PhD; Dechun Li, MD, PhD; James M. Leiper,
More informationAs outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the
3 RESULTS As outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the DKFZ in Heidelberg (Dept. of Cellular and Molecular pathology) contributed to this work by performing
More informationThe rabbit femoral artery was prepared and each arterial ring was permeabilized
Online Supplement Nakmura et al. cgmp-dependent relaxation of smooth muscle Materials and Methods Measurement of tension The rabbit femoral artery was prepared and each arterial ring was permeabilized
More informationSupplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers
Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers Medical parameters Cut-off values BMI (kg/m 2 ) 25.0 Waist (cm) (Men and Women) (Men) 85, (Women) 90
More informationSupplementary Figure 1:
Supplementary Figure 1: (A) Whole aortic cross-sections stained with Hematoxylin and Eosin (H&E), 7 days after porcine-pancreatic-elastase (PPE)-induced AAA compared to untreated, healthy control aortas
More informationSalt Sensitivity in Blacks
ONLINE SUPPLEMENT Salt Sensitivity in Blacks Evidence That the Initial Pressor Effect of NaCl Involves Inhibition of Vasodilatation by Asymmetrical Dimethylarginine Olga Schmidlin 1, Alex Forman 1, Anna
More informationIslet viability assay and Glucose Stimulated Insulin Secretion assay RT-PCR and Western Blot
Islet viability assay and Glucose Stimulated Insulin Secretion assay Islet cell viability was determined by colorimetric (3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay using CellTiter
More informationSalt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance
Salt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance Matthew R. Weir, MD Professor and Director Division of Nephrology University of Maryland School of Medicine Overview Introduction Mechanisms
More informationSestrin2 and BNIP3 (Bcl-2/adenovirus E1B 19kDa-interacting. protein3) regulate autophagy and mitophagy in renal tubular cells in. acute kidney injury
Sestrin2 and BNIP3 (Bcl-2/adenovirus E1B 19kDa-interacting protein3) regulate autophagy and mitophagy in renal tubular cells in acute kidney injury by Masayuki Ishihara 1, Madoka Urushido 2, Kazu Hamada
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION FOR Liver X Receptor α mediates hepatic triglyceride accumulation through upregulation of G0/G1 Switch Gene 2 (G0S2) expression I: SUPPLEMENTARY METHODS II: SUPPLEMENTARY FIGURES
More informationSupplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells
Supplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells (b). TRIM33 was immunoprecipitated, and the amount of
More informationSupplementary Fig. 1. Identification of acetylation of K68 of SOD2
Supplementary Fig. 1. Identification of acetylation of K68 of SOD2 A B H. sapiens 54 KHHAAYVNNLNVTEEKYQEALAK 75 M. musculus 54 KHHAAYVNNLNATEEKYHEALAK 75 X. laevis 55 KHHATYVNNLNITEEKYAEALAK 77 D. rerio
More informationSUPPLEMENTAL DATA. Lumen area ( m 2 )
Elastin Lumen area ( m 2 ) Media to lumen ratio (x1) H.E. Medium thickness ( m) Medium area ( m 2 ) SUPPLEMENTAL DATA A (Bmal1 flox/flox ) (SM-Bmal1 -/- ) B 1 8 8 6 6 4 4 2 2 1µm 5 8 4 6 3 2 4 1 2 Supplemental
More informationH 2 S: Synthesis and functions
H 2 S: Synthesis and functions 1 Signaling gas molecules: O 2, NO and CO Then, H 2 S - Fourth singling gas molecule after O 2, NO and CO 2 Nothing Rotten About Hydrogen Sulfide s Medical Promise Science
More informationDirect blood pressure monitoring was done using radiotelemetry (DataSciences
Supplemental Methods: Blood Pressure Monitoring Direct blood pressure monitoring was done using radiotelemetry (DataSciences International; DSI). Surgical implantation of TA11PA-C1 transmitters was performed
More informationGeneral Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry:
General Laboratory methods Plasma analysis: Plasma insulin (Mercodia, Sweden), leptin (duoset, R&D Systems Europe, Abingdon, United Kingdom), IL-6, TNFα and adiponectin levels (Quantikine kits, R&D Systems
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationSupplemental Information
Supplemental Information Tobacco-specific Carcinogen Induces DNA Methyltransferases 1 Accumulation through AKT/GSK3β/βTrCP/hnRNP-U in Mice and Lung Cancer patients Ruo-Kai Lin, 1 Yi-Shuan Hsieh, 2 Pinpin
More informationRelation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population
(2003) 17, 555 559 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationMSMS measurement of new biomarkers of liver and kidney functions and brain damage
MSMS measurement of new biomarkers of liver and kidney functions and brain damage Asian Pacific Conference of Chromatography & Mass Spectrometry 2010 14 th -16 th January 2010 R Neil Dalton & Charles Turner
More informationOxalate (urine, plasma)
Oxalate (urine, plasma) 1 Name and description of analyte 1.1 Name of analyte Oxalate 1.2 Alternative names 1.3 NLMC code To follow 1.4. Function of analyte Oxalate is a metabolic end product primarily
More informationFONS Nové sekvenační technologie vklinickédiagnostice?
FONS 2010 Nové sekvenační technologie vklinickédiagnostice? Sekvenování amplikonů Sequence capture Celogenomové sekvenování FONS 2010 Sekvenování amplikonů Amplicon sequencing - amplicon sequencing enables
More informationMammalian Tissue Protein Extraction Reagent
Mammalian Tissue Protein Extraction Reagent Catalog number: AR0101 Boster s Mammalian Tissue Protein Extraction Reagent is a ready-to-use Western blot related reagent solution used for efficient extraction
More informationImproving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology
Improving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology Pongkwan (Nikki) Sitasuwan, Margarita Marinova, and L. Andrew Lee Integrated Micro-Chromatography Systems, LLC
More informationCell Lysis Buffer. Catalog number: AR0103
Cell Lysis Buffer Catalog number: AR0103 Boster s Cell Lysis Buffer is a ready-to-use Western blot related reagent solution used for efficient extraction of total soluble protein in nondenatured state
More information(Stratagene, La Jolla, CA) (Supplemental Fig. 1A). A 5.4-kb EcoRI fragment
SUPPLEMENTAL INFORMATION Supplemental Methods Generation of RyR2-S2808D Mice Murine genomic RyR2 clones were isolated from a 129/SvEvTacfBR λ-phage library (Stratagene, La Jolla, CA) (Supplemental Fig.
More informationPTM Discovery Method for Automated Identification and Sequencing of Phosphopeptides Using the Q TRAP LC/MS/MS System
Application Note LC/MS PTM Discovery Method for Automated Identification and Sequencing of Phosphopeptides Using the Q TRAP LC/MS/MS System Purpose This application note describes an automated workflow
More informationNOS Activity Assay Kit
NOS Activity Assay Kit Catalog Number KA1345 50 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Principle of the Assay... 3 General Information... 4
More informationPrenatal hypoxia causes long-term alterations in vascular endothelin-1 function in aged male but not female offspring
1 2 3 4 5 6 7 8 9 1 11 12 13 14 Supplementary information for: Prenatal hypoxia causes long-term alterations in vascular endothelin-1 function in aged male but not female offspring Stephane L Bourque,
More informationIDEXX Catalyst SDMA Test for in-house measurement of SDMA concentration in serum from dogs and cats
IDEXX Catalyst SDMA Test for in-house measurement of SDMA in serum from dogs and cats By Graham Bilbrough, Barbara Evert, Karen Hathaway, Gina Panagakos, Jane Robertson, and Maha Yerramilli Introduction
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Clinical perspective It was recently discovered that small RNAs, called micrornas, circulate freely and stably in human plasma. This finding has sparked interest in the potential
More information2D protein gel analysis tool for studying the protein phosphorylation changes associated with contraction and relaxation of vascular smooth muscle
2D protein gel analysis tool for studying the protein phosphorylation changes associated with contraction and relaxation of vascular smooth muscle Internship details Where: Department of Bioengineering
More informationExpression of acid base transporters in the kidney collecting duct in Slc2a7 -/-
Supplemental Material Results. Expression of acid base transporters in the kidney collecting duct in Slc2a7 -/- and Slc2a7 -/- mice. The expression of AE1 in the kidney was examined in Slc26a7 KO mice.
More informationLecture 1 and 2 ONE. Definitions. Pharmacology: the study of the interaction of drugs within living systems
Lecture 1 and 2 ONE 1. Explain what pharmacology encompasses and how it relates to other disciplines 2. Discuss the types of drug target and the factors that influence the binding of drugs to these targets
More informationThe distribution of log 2 ratio (H/L) for quantified peptides. cleavage sites in each bin of log 2 ratio of quantified. peptides
Journal: Nature Methods Article Title: Corresponding Author: Protein digestion priority is independent of their abundances Mingliang Ye and Hanfa Zou Supplementary Figure 1 Supplementary Figure 2 The distribution
More informationComparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation
IJMS Vol 34, No 2, June 2009 Original Article Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation Reza Hekmat, Hamid Eshraghi Abstract Background:
More informationSupplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of
Supplemental Figure Legends Supplemental Figure 1. Western blot analysis indicated that was detected in the fractions of plasma membrane and cytosol but not in nuclear fraction isolated from Pkd1 null
More informationUrea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training
Urea Cycle Defects Dr Mick Henderson Biochemical Genetics Leeds Teaching Hospitals Trust The Urea Cycle The urea cycle enables toxic ammonia molecules to be converted to the readily excreted and non toxic
More informationEffects and mechanisms of Fenofibrate on the secretion of vascular endothelial contraction factors in hypertensive rats
Effects and mechanisms of Fenofibrate on the secretion of vascular endothelial contraction factors in hypertensive rats Y. Zhu 1, H.-S. Wang 1, X.-M. Li 1 and C. Qu 2 1 Department of Cardiac Surgery, General
More informationSupplementary Figure 1
Supplementary Figure 1 Asymmetrical function of 5p and 3p arms of mir-181 and mir-30 families and mir-142 and mir-154. (a) Control experiments using mirna sensor vector and empty pri-mirna overexpression
More informationDementia. Inhibition of vascular calcification
FLEMENGHO Dementia Inhibition of vascular calcification Role of matrix Gla protein Yan-Ping Liu, Fang-Fei Wei, Cees Vermeer, and Jan A. Staessen, Research Unit Hypertension and Cardiovascular Epidemiology,
More informationImprove Protein Analysis with the New, Mass Spectrometry- Compatible ProteasMAX Surfactant
Improve Protein Analysis with the New, Mass Spectrometry- Compatible Surfactant ABSTRACT Incomplete solubilization and digestion and poor peptide recovery are frequent limitations in protein sample preparation
More informationDetermination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay
Clin Chem Lab Med 2004;42(12):1377 1383 2004 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2004.257 Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay Friedrich Schulze
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationHEK293FT cells were transiently transfected with reporters, N3-ICD construct and
Supplementary Information Luciferase reporter assay HEK293FT cells were transiently transfected with reporters, N3-ICD construct and increased amounts of wild type or kinase inactive EGFR. Transfections
More informationMitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit
PROTOCOL Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit DESCRIPTION Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit Sufficient materials
More informationUrinary 8-Isoprostane ELISA kit
Urinary 8-Isoprostane ELISA kit Catalog Number: 8isoU Store at -20 C. FOR RESEARCH USE ONLY V.020420 Introduction This competitive ELISA kit is for determination of free and glucronidated 8-isoprostane
More informationLecture 10 - Protein Turnover and Amino Acid Catabolism
Lecture 10 - Protein Turnover and Amino Acid Catabolism Chem 454: Regulatory Mechanisms in Biochemistry University of Wisconsin-Eau Claire 1 Introduction 2 Proteins are degraded into amino acids. Protein
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationExercise in Adverse Cardiac Remodeling: of Mice and Men
Exercise in Adverse Cardiac Remodeling: of Mice and Men 17-01-2013 Dirk J Duncker Experimental Cardiology, Cardiology, Thoraxcenter Cardiovascular Research Institute COEUR Erasmus MC, University Medical
More informationProf. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland.
What could be the role of renal denervation in chronic kidney disease? Andrzej Wiecek, Katowice, Poland Chairs: Peter J. Blankestijn, Utrecht, The Netherlands Jonathan Moss, Glasgow, UK Prof. Andrzej Wiecek
More informationMeasurement of Renin Activity using Tandem Mass Spectrometry Ravinder J Singh, PhD, DABCC Mayo Clinic, Rochester, MN
Measurement of Renin Activity using Tandem Mass Spectrometry Ravinder J Singh, PhD, DABCC Mayo Clinic, Rochester, MN Renin Angiotension System Weber, et al. NEJM 2001; 345:1690. Renin Angiotension System
More informationSupplementary Fig. 1. GPRC5A post-transcriptionally down-regulates EGFR expression. (a) Plot of the changes in steady state mrna levels versus
Supplementary Fig. 1. GPRC5A post-transcriptionally down-regulates EGFR expression. (a) Plot of the changes in steady state mrna levels versus changes in corresponding proteins between wild type and Gprc5a-/-
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationInstruction for Use SDMA ELISA
Instruction for Use SDMA ELISA Enzyme Immunoassay for the Quantitative Determination of Endogenous Symmetric Dimethylarginine (SDMA) in Serum or Plasma REF EA203/96 12 x 8 2 8 C I V D DLD Gesellschaft
More informationSupplementary Online Content
Supplementary Online Content Nikolova AP, Hitzeman TC, Baum R, et al. Association of a novel diagnostic biomarker, the plasma cardiac bridging integrator 1 score, with heart failure with preserved ejection
More informationHasan Fattah 3/19/2013
Hasan Fattah 3/19/2013 AASK trial Rational: HTN is a leading cause of (ESRD) in the US, with no known treatment to prevent progressive declines leading to ESRD. Objective: To compare the effects of 2 levels
More informationLuminescent platforms for monitoring changes in the solubility of amylin and huntingtin in living cells
Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2016 Contents Supporting Information Luminescent platforms for monitoring changes in the
More informationDetermination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.
Page 1 of 10 Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection EPL-BAS Method No. 205G881B Method Summary: Residues of 6-CPA are
More informationPCTH 400. Endothelial dysfunction and cardiovascular diseases. Blood vessel LAST LECTURE. Endothelium. High blood pressure
PCTH 400 LAST LECTURE Endothelial dysfunction and cardiovascular diseases. Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure Blood pressure
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationDuring the hyperinsulinemic-euglycemic clamp [1], a priming dose of human insulin (Novolin,
ESM Methods Hyperinsulinemic-euglycemic clamp procedure During the hyperinsulinemic-euglycemic clamp [1], a priming dose of human insulin (Novolin, Clayton, NC) was followed by a constant rate (60 mu m
More informationRole of Paired Box9 (PAX9) (rs ) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis
EC Dental Science Special Issue - 2017 Role of Paired Box9 (PAX9) (rs2073245) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis Research Article Dr. Sonam Sethi 1, Dr. Anmol
More informationBin Liu, Lei Yang, Binfang Huang, Mei Cheng, Hui Wang, Yinyan Li, Dongsheng Huang, Jian Zheng,
The American Journal of Human Genetics, Volume 91 Supplemental Data A Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Survival of Lung Cancer Bin Liu, Lei Yang, Binfang Huang, Mei Cheng,
More informationThe endogenous methylarginines N G, N G -dimethyl-larginine
Brief Review Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease Markers, Mediators, and Regulators? Ben Caplin, James Leiper Abstract The asymmetric methylarginines inhibit nitric oxide
More informationHYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg
Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between
More informationSupplementary Information
Supplementary Information NEPRILYSIN IS A MEDIATOR OF ALTERNATIVE RENIN- ANGIOTENSIN- SYSTEM ACTIVATION IN THE MURINE AND HUMAN KIDNEY Oliver Domenig 1#, Arndt Manzel 2#, Nadja Grobe 3, Eva Koenigshausen
More informationDr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.
The uric acid dilemma: causal risk factor for hypertension and CKD or mere bystander? Mehmet Kanbay, Istanbul, Turkey Chairs: Anton H. van den Meiracker, Rotterdam, The Netherlands Claudia R.C. Van Roeyen,
More informationFigure S1. Reduction in glomerular mir-146a levels correlate with progression to higher albuminuria in diabetic patients.
Supplementary Materials Supplementary Figures Figure S1. Reduction in glomerular mir-146a levels correlate with progression to higher albuminuria in diabetic patients. Figure S2. Expression level of podocyte
More informationSUPPLEMENTARY INFORMATION
DOI: 10.1038/ncb2607 Figure S1 Elf5 loss promotes EMT in mammary epithelium while Elf5 overexpression inhibits TGFβ induced EMT. (a, c) Different confocal slices through the Z stack image. (b, d) 3D rendering
More informationA complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis
APPLICATION NOTE Cell-Free DNA Isolation Kit A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis Abstract Circulating cell-free DNA (cfdna) has been shown
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationAmino Acid Oxidation and the Urea Cycle
Amino Acid Oxidation and the Urea Cycle Amino Acids: Final class of biomolecules whose oxidation contributes significantly to the generation of energy Undergo oxidation in three metabolic circumstances
More informationSUPPLEMENTARY INFORMATION
Supplementary Figures Supplementary Figure S1. Binding of full-length OGT and deletion mutants to PIP strips (Echelon Biosciences). Supplementary Figure S2. Binding of the OGT (919-1036) fragments with
More informationPaul M McKie, Alessandro Cataliotti, Guido Boerrigter, Horng C Chen, Fernando L Martin, and John C Burnett Jr
Cardiorenal Enhancing and Aldosterone Suppressing Actions of a Novel Designer Natriuretic Peptide in Experimental Hypertension with Ventricular Pressure Overload Paul M McKie, Alessandro Cataliotti, Guido
More informationChapter 15 Fluid and Acid-Base Balance
Chapter 15 Fluid and Acid-Base Balance by Dr. Jay M. Templin Brooks/Cole - Thomson Learning Fluid Balance Water constitutes ~60% of body weight. All cells and tissues are surrounded by an aqueous environment.
More informationCASE 13. What neural and humoral pathways regulate arterial pressure? What are two effects of angiotensin II?
CASE 13 A 57-year-old man with long-standing diabetes mellitus and newly diagnosed hypertension presents to his primary care physician for follow-up. The patient has been trying to alter his dietary habits
More informationProtocol for Gene Transfection & Western Blotting
The schedule and the manual of basic techniques for cell culture Advanced Protocol for Gene Transfection & Western Blotting Schedule Day 1 26/07/2008 Transfection Day 3 28/07/2008 Cell lysis Immunoprecipitation
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More information1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias
1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should
More informationRecombinant Protein Expression Retroviral system
Recombinant Protein Expression Retroviral system Viruses Contains genome DNA or RNA Genome encased in a protein coat or capsid. Some viruses have membrane covering protein coat enveloped virus Ø Essential
More informationMinute TM Plasma Membrane Protein Isolation and Cell Fractionation Kit User Manual (v5)
Minute TM Plasma Membrane Protein Isolation and Cell Fractionation Kit Catalog number: SM-005 Description Minute TM plasma membrane (PM) protein isolation kit is a novel and patented native PM protein
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationChronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis
Chronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis Benedict Phillips 1, Kerem Atalar 1, Hannah Wilkinson 1, Nicos Kessaris
More informationattomol HLA-B*27-Realtime LT 2 Assay for the detection of the human HLA-B*27-locus using LightCycler (Do not use for tissue typing!
attomol HLA-B*27-Realtime LT 2 Assay for the detection of the human HLA-B*27-locus using LightCycler (Do not use for tissue typing!) For in vitro diagnostic use only! 50 determinations Order number: 95
More informationThe Force is in the cfdna. Roy D. Bloom MD University of Pennsylvania
The Force is in the cfdna Roy D. Bloom MD University of Pennsylvania Disclosures Advisor: Veloxis, CSL Behring Royalties: UpToDate Research support: CareDx, Veloxis, Shire Nephrocentric presentation Road
More informationFunctional regulation of vascular and platelet activity during thrombosis by nitric. Christopher Moore, Charalambos Tymvios and Michael Emerson
Page of Thrombosis and Haemostasis Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase Christopher Moore, Charalambos Tymvios
More informationSupplementary Figure 1. AdipoR1 silencing and overexpression controls. (a) Representative blots (upper and lower panels) showing the AdipoR1 protein
Supplementary Figure 1. AdipoR1 silencing and overexpression controls. (a) Representative blots (upper and lower panels) showing the AdipoR1 protein content relative to GAPDH in two independent experiments.
More informationThis student paper was written as an assignment in the graduate course
77:222 Spring 2005 Free Radicals in Biology and Medicine Page 0 This student paper was written as an assignment in the graduate course Free Radicals in Biology and Medicine (77:222, Spring 2005) offered
More informationSorafenib (free base, >99%) was obtained from Chemie Tek (Indianapolis, IN), and
Supplemental Methods Chemicals and Reagents Sorafenib (free base, >99%) was obtained from Chemie Tek (Indianapolis, IN), and isotopically-labeled 13 C- 2 H 3 -sorafenib (labeled atoms on N-methyl position)
More information